This Tuesday and Wednesday Kanteron Systems was invited to participate in Microsoft’s 5th Health Innovation event, in the Exhibition Area, along with 5 other selected partners.
Titled “EmpoweringHealth: the journey towards more personalized, productive, collaborative and predictive health services & systems” it took place at the Microsoft Executive Briefing Center in Brussels.Kanteron Systems‘ CEO, Jorge Cortell, participated in the round table “Medical Imaging Storage in the Cloud”, moderated by Kelly Limonte (Microsoft UK Healthcare Team), and in the Expert Panel “The future of preventive and predictive health powered by data in the intelligent cloud”, along with:
InnDEA Valencia Foundation, through the VIT Salud Innovation Network, released yesterday the report “Valencia: Healthcare Innovation and Research”, produced by the Valencian Institute of Economic Research (IVIE).
Javier Quesada, author of the report, is an IVIE researcher and Professor of Economic Analysis at Valencia University (UV). The report highlights that the healthcare economic activity in the city has grown “much faster” than the rest of the economic activity and it represents 5,3% of all economic activity in the city.
Kanteron Systems today announced a partnership with IBM that brings the power of Medical Imaging Analysis to the IBM Cloud marketplace. Starting today, IBM clients can integrate very specific tools for medical image processing and analysis into their workflows with the click of a button.
The first available digital pathology image algorithms perform color separation for Hematoxylin, Eosin and Diaminobenzidine immunohistochemical staining.
The IBM Cloud marketplace offers client’s access to more than 100 SaaS applications, IBM‘s Bluemix™ platform-as-a-service with its suite of composable services, the powerful SoftLayer infrastructure-as-a-service and IBM‘s rich intellectual capital and deep industry expertise.
The TIC Salud National HealthIT Innovation Touris an initiative that organizes events in different Spanish regions so that companies in the industry can present their latest innovations in the field of HealthIT to healthcare professionals and executives. The Committee will be formed by deputy directors of Information Technology, CEO‘s, CIO‘s and medical directors. Following each of the presentations, committee members will ask questions directed to the speakers about their innovations.
MarketsandMarketsrecently published “Digital Pathology Market by Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/Cloud Based) & by Whole Slide Image Storage – Global Forecasts & Trends to 2018″ (available for purchase online), listing Kanteron Systems as a “major player"in the worldwide Digital Pathology market.
This report covers the definition, description, and forecast of the digital pathology market in terms of products and applications; the digital pathology market comprises of scanners, analytics, storage, and communication.
Kanteron Systems has been featured as VNA (Vendor-Neutral Archive) sample vendor in Gartner‘s latest healthcare technology report: Hype Cycle for Healthcare Providers Technologies and Standards, written by veteran industry analyst Barry Runyon.
The Hype Cycle for Healthcare Providers Technologies and Standards is a vital reference for healthcare delivery organization CIOs and IT leadership when assessing the value of existing and emerging information technologies and standards. It provides insight necessary to remain competitive in a rapidly evolving healthcare provider marketplace.
Kanteron Systems is proud to announce it has joined institutions like Broad Institute of MIT and Harvard, American Society of Clinical Oncology, Massachusetts General Hospital, Mayo Clinic, Johns Hopkins University School of Medicine, Memorial Sloan-Kettering Cancer Center, IBM, or Google, in the Global Alliance for Genomics and Health.
The Global Alliance for Genomics and Health (Global Alliance) is an international coalition, formed by over 150 of the world’s leading organizations (including healthcare providers, research funders, research institutions, disease advocacy organizations, and life science and information technology companies) to enable the sharing of genomic and clinical data.
